What is retinal panel?

What is retinal panel?

Test description The Invitae Inherited Retinal Disorders Panel analyzes genes that are associated with inherited retinal disorders including but not limited to retinitis pigmentosa, cone-rod dystrophy and Leber congenital amaurosis.

What is hereditary retinal dystrophy?

Retinal dystrophies are a heterogeneous group of hereditary diseases that cause progressive and severe loss of vision by altering the anatomy and/or function of the retina. There is currently no cure, but research is being carried out to find ways of treating it in the coming years with gene and cell therapies.

What is the most likely cause of this patient’s night blindness?

The most common cause of nyctalopia is retinitis pigmentosa, a disorder in which the rod cells in the retina gradually lose their ability to respond to the light. Patients suffering from this genetic condition have progressive nyctalopia and eventually, their daytime vision may also be affected.

Does Invitae test for autism?

Pediatric testing Chromosomal microarray for developmental disorders – Invitae offers microarray testing for individuals with developmental disorders, congenital anomalies and/or autism spectrum disorder. Our testing evaluates for chromosomal abnormalities that can result in disorders of development.

Does retinal dystrophy always cause blindness?

Retinal dystrophies (RDs) are degenerative diseases of the retina which have marked clinical and genetic heterogeneity. Common presentations among these disorders include night or colour blindness, tunnel vision and subsequent progression to complete blindness.

Can retinal dystrophy be treated?

There is currently no cure for RP, and no proven treatments are available to slow the progression of the disease.

What is the difference between dystrophy and degeneration?

Degenerations are usually unilateral, asymmetric and often peripheral. Changes caused by inflammation, maturity or systemic disease result in deposition, thinning or vascularization of the corneal tissue. Dystrophies are rare conditions and may not present in a primary setting.

Is retinal dystrophy hereditary?

Most retinal dystrophies are genetic. This means they are caused by a mistake in a person’s genes and both eyes are likely to be affected. Often the gene mistake has been passed (inherited) from one or both parents. There are a number of different ways in which this can happen (see ‘Inheritance’ section).

What causes night time blindness?

Night blindness caused by nearsightedness, cataracts, or vitamin A deficiency is treatable. Corrective lenses, such as eyeglasses or contacts, can improve nearsighted vision both during the day and at night. Let your doctor know if you still have trouble seeing in dim light even with corrective lenses.

What does pattern dystrophy of the retina mean?

HISHAM ALKURAYA, MD ∙ KANG ZHANG, MD, PhD. Pattern dystrophy (PD) of the retinal pigment epithelium (RPE) refers to a heterogeneous group of dominantly inherited macular diseases characterized by the development of a variety of patterns of deposits of the yellow, orange, or gray pigment in the macular area ( Figure 1 ).

How can you tell if you have retinal dystrophy?

To give an accurate diagnosis of RP, a number of tests may need to be performed by an ophthalmologist who has special training in managing retinal or genetic eye diseases. Tests undertaken will establish how well your retina is functioning. Visual acuity – a test used to determine ones visual clarity.

Is there a cure for retinal dystrophy ( RP )?

Blood sample may be requested for genetic analysis of known mutations that cause retinitis pigmentosa or similar disorders. There is currently no cure for RP, and no proven treatments are available to slow the progression of the disease.

How are sunglasses used to treat retinal dystrophy?

Light avoidance – the use of sunglasses have been found to be helpful when protecting the retina from ultraviolet light, however this is only a vision-preserving effect. Antioxidants – antioxidant agents may be useful in treating patients with RP but no strong evidence currently exists.